Treatment of type 1 diabetes with pde5 inhibitors

Details Treatment of type 1 diabetes with pde5 inhibitors Treatment of type 1 diabetes with pde5 inhibitors

A - Human Necessities

61

K

A61K 31/00 (2006.01) A61K 31/22 (2006.01) A61K 31/366 (2006.01) A61K 31/40 (2006.01) A61K 31/405 (2006.01) A61K 31/4535 (2006.01) A61K 31/4709 (2006.01) A61K 31/506 (2006.01) A61K 31/519 (2006.01) A61K 31/53 (2006.01) A61K 38/28 (2006.01) A61P 3/10 (2006.01)

Patent

CA 2519357

The use of a PDE5 inhibitor without substantial PDE2 inhibiting activity, or a pharmaceutically acceptable salt thereof in the preparation of a medicament for the treatment of Type 1 Diabetes. A method of treating Type 1 Diabetes in an individual suffering from Type 1 Diabetes, which method comprises administering to said individual an effective amount of a PDE5 inhibitor without substantial PDE2 inhibiting activity, or a pharmaceutically acceptable salt thereof.

Utilisation d'un inhibiteur de PDE5 n'ayant sensiblement aucune activité inhibitrice de PDE2, ou de son sel pharmaceutiquement acceptable, dans la préparation d'un médicament destiné au traitement du diabète insulino-dépendant. Procédé de traitement du diabète insulino-dépendant chez un sujet souffrant de diabète insulino-dépendant, ce procédé consistant à administrer audit sujet une quantité efficace d'un inhibiteur de PDE5 n'ayant sensiblement aucune activité inhibitrice de PDE2, ou de son sel pharmaceutiquement acceptable.

Affiliated with

Also associated with

Rating

Treatment of type 1 diabetes with pde5 inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of type 1 diabetes with pde5 inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of type 1 diabetes with pde5 inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1688611